Literature DB >> 25199678

Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma.

Tjinta Brinkhuizen1, Marie G Reinders2, Michel van Geel3, Annelot J L Hendriksen4, Aimée D C Paulussen5, Véronique J Winnepenninckx6, Kristien B Keymeulen7, Patricia M M B Soetekouw8, Maurice A M van Steensel9, Klara Mosterd2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25199678     DOI： 10.1016/j.jaad.2014.08.001

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  21 in total

Review 1.  Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma.

Authors:  Celeste B Burness; Lesley J Scott
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

2.  MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.

Authors:  Lucile Hoch; Helene Faure; Hermine Roudaut; Angele Schoenfelder; Andre Mann; Nicolas Girard; Laure Bihannic; Olivier Ayrault; Elena Petricci; Maurizio Taddei; Didier Rognan; Martial Ruat
Journal:  FASEB J       Date:  2015-01-30       Impact factor: 5.191

3.  Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.

Authors:  Hayley J Sharpe; Gregoire Pau; Gerrit J Dijkgraaf; Nicole Basset-Seguin; Zora Modrusan; Thomas Januario; Vickie Tsui; Alison B Durham; Andrzej A Dlugosz; Peter M Haverty; Richard Bourgon; Jean Y Tang; Kavita Y Sarin; Luc Dirix; David C Fisher; Charles M Rudin; Howard Sofen; Michael R Migden; Robert L Yauch; Frederic J de Sauvage
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

Review 4.  Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience.

Authors:  Salvatore Alfieri; Cristiana Bergamini; Roberta Granata; Laura Locati; Lisa Licitra; Paolo Bossi
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

Review 5.  Smoothened goes molecular: new pieces in the hedgehog signaling puzzle.

Authors:  Jacqueline M McCabe; Daniel J Leahy
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

6.  Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.

Authors:  Markus Eberl; Doris Mangelberger; Jacob B Swanson; Monique E Verhaegen; Paul W Harms; Marcus L Frohm; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cancer Cell       Date:  2018-01-27       Impact factor: 31.743

7.  The use of hedgehog antagonists in cancer therapy: a comparison of clinical outcomes and gene expression analyses.

Authors:  Burthia E Booker; Adam D Steg; Stefan Kovac; Charles N Landen; Hope M Amm
Journal:  Cancer Biol Ther       Date:  2020-09-11       Impact factor: 4.742

8.  Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-15

9.  HDAC1/2 Control Proliferation and Survival in Adult Epidermis and Pre‒Basal Cell Carcinoma through p16 and p53.

Authors:  Xuming Zhu; Matthew Leboeuf; Fang Liu; Marina Grachtchouk; John T Seykora; Edward E Morrisey; Andrzej A Dlugosz; Sarah E Millar
Journal:  J Invest Dermatol       Date:  2021-07-18       Impact factor: 8.551

Review 10.  Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.

Authors:  Leslie A Fecher; William H Sharfman
Journal:  Biologics       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.